Piper Sandler & Co’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-80,000
Closed -$334K 135
2014
Q4
$334K Buy
+80,000
New +$368K 0.16% 47

Other funds holding NEO

Piper Sandler & Co's NEO Position: Q1 2015 in Review

Piper Sandler & Co sold out of NeoGenomics (NEO) in Q1 2015, closing a stake of 80,000 shares — an estimated $334K sold.

Piper Sandler & Co first reported a position in NEO in Q4 2014 and held it in 1 quarter. The position peaked at $334K in Q4 2014. 84 funds tracked by Wall St. Rank hold NEO as of Q1 2015.

  • Piper Sandler & Co reported no remaining NeoGenomics position as of Q1 2015 after selling out during the quarter.
  • Piper Sandler & Co sold 80,000 NeoGenomics shares in Q1 2015, an estimated $334K.
  • Piper Sandler & Co first reported a position in NeoGenomics in Q4 2014 and held it in 1 quarter.
  • Piper Sandler & Co's NeoGenomics position peaked at $334K in Q4 2014.
  • 84 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2015.

Based on Piper Sandler & Co's 13F filing for Q1 2015, filed 15 May 2015.